UPC CFI 202/2025
Mar 6, 2025·EP3646825 · A SYSTEM COMPRISING A PROSTHETIC VALVE AND A DELIVERY CATHETER
- Case details
- StatusCase Closed (Settled)ActionProvisional measuresCategoryProvisional measures
- Parties
- Claimants
- Edwards Lifesciences CorporationOperating co.
Representatives- Siddharth Kusumakar-Powell Gilbert (Europe) LLP
- Bryce Matthewson-Powell Gilbert (Europe) LLP
- Adam Rimmer-Powell Gilbert (Europe) LLP
Respondents- Sintec S.r.l.Operating co.
- Value Med S.r.l.Operating co.
Representatives- Giovanni Ghirardi
- Francesco Banterle
- Andrea Schettino
- Andreas von Falck-Hogan Lovells International LLP
- Roman Würtenberger-Hogan Lovells International LLP
- Beatrice Wilden-Hogan Lovells International LLP
- Division
- Milan LD
- Technology
- InstrumentsMedical technology
- Language
- English
| Preliminary injunction granted | Median days to first decision | |
|---|---|---|
| All UPC | 54% (38/70) | 124 |
| Milan LD | Locked | Locked |
| Judge Pierluigi Perrotti | Locked | Locked |
| Judge Margot Kokke | Locked | Locked |
| Judge Alima Zana | Locked | Locked |
At the UPC: Edwards Lifesciences Group (57 cases)·Sintec S.r.l. (1 case)
15 other defendants litigating the same or a related patent
UPC CoA 166/2025·UPC CoA 21/2025·UPC CoA 27/2025·UPC CFI 815/2024·UPC CFI 674/2024 and 10 more
- 2025-09-05Application RoP 365Public
Summary: Milan Local Division confirmed the settlement agreement between Edwards Lifesciences and the respondents (Sintec and Value Med) in provisional measures proceedings concerning EP 3 646 825. The Court confirmed the settlement under Art. 79 UPCA and R.365 RoP, making it enforceable as a final decision. The request for reimbursement of 60% of court fees was dismissed.
Show the legal issues (3)
- Confirmation of settlement under Art. 79 UPCA and R.365 RoP
- Enforceability of confirmed settlement
- Court fee reimbursement
| Document title | Date | Public |
|---|---|---|
| Case closed | 2025-11-25 | Not public |
| Outcome of the Order | 2025-09-05 | Not public |
| decision 365 rop | 2025-09-05 | Public |
| Comments pursuant to RoP264 | 2025-07-30 | Not public |
| Comments pursuant to RoP264 | 2025-07-30 | Not public |
| preliminary order | 2025-07-23 | Not public |
| Comments pursuant to RoP264 | 2025-07-17 | Not public |
| Exhibit HL 2-App | 2025-07-17 | Not public |
| Comments pursuant to RoP264 | 2025-07-17 | Not public |
| Exhibit HL 2-App | 2025-07-17 | Not public |
Edwards Lifesciences Corporation's application for provisional measures against Sintec s.r.l. and Value Med s.r.l. concerning EP 3 646 825 (prosthetic valve delivery system) settled following judge-rapporteur-facilitated negotiations at the Milan Local Division. The Court confirmed the settlement as an enforceable final decision under Art. 79 UPCA and R. 365 RoP, but dismissed Edwards' request for 60% reimbursement of court fees.
Settlement agreement between Edwards Lifesciences and Sintec/Value Med to be confirmed as enforceable decision under Art. 79 UPCA and R. 365.1 RoP
ClaimantLegal basis: Art. 79 UPCA; R. 365.1 RoPNote: Court confirmed the settlement signed 23 June 2025 and made it enforceable as a final court decision.
Redacted version of settlement to be published, with full text confidential
ClaimantLegal basis: R. 365 RoPNote: Court ordered publication of redacted version only.
60% reimbursement of court fees (EUR 6,600) requested by Edwards under R. 370.9(c) and 370.11 RoP
ClaimantLegal basis: R. 370.9(c) RoP; R. 370.11 RoPReason: Request for court fee reimbursement was dismissed; specific grounds not reproduced in the available excerpt.